Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bicycle Therapeutics (BCYC) Return on Assets (2019 - 2025)

Historic Return on Assets for Bicycle Therapeutics (BCYC) over the last 7 years, with Q3 2025 value amounting to 0.32%.

  • Bicycle Therapeutics' Return on Assets fell 1600.0% to 0.32% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.32%, marking a year-over-year decrease of 1600.0%. This contributed to the annual value of 0.23% for FY2024, which is 1300.0% up from last year.
  • As of Q3 2025, Bicycle Therapeutics' Return on Assets stood at 0.32%, which was down 1600.0% from 0.29% recorded in Q2 2025.
  • In the past 5 years, Bicycle Therapeutics' Return on Assets ranged from a high of 0.16% in Q3 2024 and a low of 0.33% during Q2 2023
  • Moreover, its 5-year median value for Return on Assets was 0.27% (2021), whereas its average is 0.25%.
  • Its Return on Assets has fluctuated over the past 5 years, first surged by 1500bps in 2024, then plummeted by -1600bps in 2025.
  • Over the past 5 years, Bicycle Therapeutics' Return on Assets (Quarter) stood at 0.18% in 2021, then crashed by -62bps to 0.29% in 2022, then fell by -1bps to 0.29% in 2023, then surged by 39bps to 0.18% in 2024, then crashed by -80bps to 0.32% in 2025.
  • Its Return on Assets stands at 0.32% for Q3 2025, versus 0.29% for Q2 2025 and 0.23% for Q1 2025.